Resverlogix Corp. Cash Flow Conversion Efficiency

Latest as of June 2026: 0.010x

Resverlogix Corp. cash flow conversion efficiency. Based on the latest financial reports, Resverlogix Corp. (RVX) has a cash flow conversion efficiency ratio of 0.010x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-925.52K ≈ $-669.51K USD) by net assets (CA$-94.12 Million ≈ $-68.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Resverlogix Corp. (2001–2025)

Cash flow conversion efficiency of Resverlogix Corp. from 2001 to 2025. This chart illustrates how Resverlogix Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View RVX stock price for real-time trading data and today's change.

Resverlogix Corp. Cash Flow Conversion Ratio Explained

Resverlogix Corp. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Resverlogix Corp. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Resverlogix Corp. ranked by their cash flow conversion efficiency. Also see RVX company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
ADS Maritime Holding Plc
OL:ADS
-0.043x
YX Precious Metals Bhd
KLSE:0250
-0.028x
Mexco Energy Corporation
NYSE MKT:MXC
0.045x
Shivam Autotech Limited
NSE:SHIVAMAUTO
-0.527x
Tandy Leather Factory Inc
NASDAQ:TLF
-0.070x
Aciselsan Acipayam Seluloz Sanayi Ve Ticaret AS
IS:ACSEL
0.026x
Daelim Trading
KO:006570
-0.034x
Lodzia
TA:LODZ
0.018x

Annual Cash Flow Conversion Efficiency for Resverlogix Corp. (2001–2025)

The table below shows the annual cash flow conversion efficiency of Resverlogix Corp. from 2001 to 2025. Review Resverlogix Corp. (RVX) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$-88.80 Million
≈ $-64.24 Million
CA$-3.73 Million
≈ $-2.69 Million
0.042x -11.77%
2024-12-31 CA$-81.73 Million
≈ $-59.13 Million
CA$-3.89 Million
≈ $-2.81 Million
0.048x +40.95%
2023-12-31 CA$-74.47 Million
≈ $-53.87 Million
CA$-2.51 Million
≈ $-1.82 Million
0.034x -43.53%
2022-12-31 CA$-59.28 Million
≈ $-42.88 Million
CA$-3.54 Million
≈ $-2.56 Million
0.060x -55.43%
2021-12-31 CA$-59.87 Million
≈ $-43.31 Million
CA$-8.02 Million
≈ $-5.80 Million
0.134x +121392.30%
2020-12-31 CA$-39.90 Million
≈ $-28.86 Million
CA$-4.40K
≈ $-3.18K
0.000x -99.96%
2019-12-31 CA$-64.11 Million
≈ $-46.38 Million
CA$-17.34 Million
≈ $-12.55 Million
0.271x +15.07%
2018-12-31 CA$-207.72 Million
≈ $-150.26 Million
CA$-48.83 Million
≈ $-35.33 Million
0.235x -21.73%
2017-12-31 CA$-83.68 Million
≈ $-60.53 Million
CA$-25.13 Million
≈ $-18.18 Million
0.300x +34.58%
2016-12-31 CA$-101.57 Million
≈ $-73.47 Million
CA$-22.67 Million
≈ $-16.40 Million
0.223x -41.21%
2015-12-31 CA$-56.43 Million
≈ $-40.82 Million
CA$-21.42 Million
≈ $-15.50 Million
0.380x +229.32%
2014-12-31 CA$-73.73 Million
≈ $-53.33 Million
CA$-8.50 Million
≈ $-6.15 Million
0.115x -44.80%
2013-12-31 CA$-63.22 Million
≈ $-45.73 Million
CA$-13.20 Million
≈ $-9.55 Million
0.209x -78.75%
2012-12-31 CA$-29.50 Million
≈ $-21.34 Million
CA$-29.00 Million
≈ $-20.98 Million
0.983x +111.21%
2011-12-31 CA$2.74 Million
≈ $1.98 Million
CA$-24.03 Million
≈ $-17.38 Million
-8.766x -95.92%
2010-12-31 CA$4.30 Million
≈ $3.11 Million
CA$-19.24 Million
≈ $-13.92 Million
-4.474x -8.91%
2009-12-31 CA$4.46 Million
≈ $3.23 Million
CA$-18.34 Million
≈ $-13.26 Million
-4.108x -266.55%
2008-12-31 CA$11.61 Million
≈ $8.40 Million
CA$-13.01 Million
≈ $-9.41 Million
-1.121x +68.96%
2007-12-31 CA$5.44 Million
≈ $3.94 Million
CA$-19.65 Million
≈ $-14.21 Million
-3.611x -137.13%
2006-12-31 CA$-1.02 Million
≈ $-738.42K
CA$-9.93 Million
≈ $-7.18 Million
9.724x +1749.37%
2005-12-31 CA$7.48 Million
≈ $5.41 Million
CA$-4.41 Million
≈ $-3.19 Million
-0.590x -166.26%
2004-12-31 CA$9.84 Million
≈ $7.12 Million
CA$-2.18 Million
≈ $-1.58 Million
-0.221x +35.03%
2003-12-31 CA$2.60 Million
≈ $1.88 Million
CA$-885.04K
≈ $-640.23K
-0.341x +29.20%
2002-12-31 CA$942.21K
≈ $681.58K
CA$-453.56K
≈ $-328.10K
-0.481x -1038.52%
2001-12-31 CA$259.64K
≈ $187.82K
CA$-10.98K
≈ $-7.94K
-0.042x --

About Resverlogix Corp.

TO:RVX Canada Biotechnology
Market Cap
$18.68 Million
CA$25.82 Million CAD
Market Cap Rank
#25164 Global
#968 in Canada
Share Price
CA$0.08
Change (1 day)
+0.00%
52-Week Range
CA$0.08 - CA$0.14
All Time High
CA$4.79
About

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID… Read more